Interestingly, a recent study carried out on three large sets of tissue microarrays of prostate cancer patients, including intermediate- and high-risk tumors, of European-American and African-American ancestry, provided evidence that the presence of TP53 missense mutations in these tumors was associated with increased T cell density [301]. The gene discussed is TP53; the disease is prostate cancer.